Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot
About Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot
"L’hôpital Edouard Herriot dispose de services d’excellence dans quasiment toutes les spécialités médicales et chirurgicales, avec des services phares : la chirurgie d’urgence, la chirurgie orthopédique, les transplantations et l’immunologie, la rhumatologie, l’hépato-gastroentérologie, la médecine et la chirurgie vasculaires, la néphrologie-dialyse, la médecine du vieillissement, le traitement des grands brulés…"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Agios Pharmaceuticals, Inc.
2
Amgen
2
Assistance Publique - Hôpitaux de Paris
1
Calcilytix Therapeutics, Inc., a BridgeBio company
1
Clinical Trials at Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot
During the past decade, Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome
2015-11-01
2018-02-01
Completed
141
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
2021-11-08
2028-12-01
Recruiting
171
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
2021-11-30
2029-06-01
Recruiting
240
Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation
2022-04-19
2025-03-12
Active, not recruiting
160
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot"
#1 collaborator was "ARC Foundation for Cancer Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot
According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" are
"Autosomal Dominant Hypocalcemia" (1 trials), "Colorectal Cancer (CRC)" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Lynch Syndrome" (1 trials) and "Non-Transfusion-dependent Alpha-Thalassemia" (1 trials). Many other conditions were trialed in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" in a lesser frequency.
Clinical Trials Intervention Types at Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot
Most popular intervention types in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Mitapivat" (2 trials), "Placebo Matching Mitapivat" (2 trials), "Colonoscopy" (1 trials), "Evolocumab" (1 trials) and "Panitumumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot
The vast majority of trials in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" are
6 trials for "All" genders.
Clinical Trials Status at Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot
Currently, there are NaN active trials in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".